# Pre-operative Administration of Sorafenib in Patients With Metastatic Renal Cell Carcinoma Undergoing Kidney Removal

> **NCT00480389** · PHASE2 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 19 (actual)

## Conditions studied

- Renal Cell Carcinoma
- Metastatic Disease

## Interventions

- **DRUG:** Sorafenib

## Key facts

- **NCT ID:** NCT00480389
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2012-10
- **Final completion:** 2013-03
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2015-12-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00480389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00480389, "Pre-operative Administration of Sorafenib in Patients With Metastatic Renal Cell Carcinoma Undergoing Kidney Removal". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00480389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*